Shopping Cart
- Remove All
- Your shopping cart is currently empty
Teclistamab, a human bispecific antibody targeting both BCMA on target cells and CD3 on T cells, facilitates T cell-mediated cytotoxicity, which results in T cell activation and subsequent target cell lysis. This compound has applications in research studies concerning multiple myeloma (MM) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $689 | 8-10 weeks | |
5 mg | $1,590 | 8-10 weeks | |
10 mg | $2,180 | 8-10 weeks | |
25 mg | $3,230 | 8-10 weeks | |
50 mg | $4,370 | 8-10 weeks | |
100 mg | $5,890 | 8-10 weeks |
Description | Teclistamab, a human bispecific antibody targeting both BCMA on target cells and CD3 on T cells, facilitates T cell-mediated cytotoxicity, which results in T cell activation and subsequent target cell lysis. This compound has applications in research studies concerning multiple myeloma (MM) [1]. |
Cas No. | 2119595-80-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.